Regional Health Financials
This page shows Regional Health (RHEPA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Regional Health passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Regional Health generates $-0.60 in operating cash flow ($1.9M OCF vs -$3.2M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Regional Health earns $0.1 in operating income for every $1 of interest expense ($161K vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Regional Health generated $18.3M in revenue in fiscal year 2024. This represents an increase of 6.8% from the prior year.
Regional Health's EBITDA was $2.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 55.0% from the prior year.
Regional Health generated $1.4M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 48.7% from the prior year.
Regional Health reported -$3.2M in net income in fiscal year 2024. This represents an increase of 17.2% from the prior year.
Regional Health earned $-1.73 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 108.2% from the prior year.
Regional Health held $582K in cash against $49.7M in long-term debt as of fiscal year 2024.
Regional Health had 2M shares outstanding in fiscal year 2024. This represents an increase of 2.2% from the prior year.
Regional Health's operating margin was 0.9% in fiscal year 2024, reflecting core business profitability. This is up 5.7 percentage points from the prior year.
Regional Health's net profit margin was -17.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 5.1 percentage points from the prior year.
Regional Health invested $530K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 44.7% from the prior year.
RHEPA Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.1M+50.5% | $10.1M+39.9% | $7.2M+27.1% | $5.7M+33.9% | $4.2M-2.3% | $4.3M+4.8% | $4.1M-8.7% | $4.5M |
| Cost of Revenue | $2.5M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $12.7M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $3.7M+52.9% | $2.4M+8.9% | $2.2M+68.6% | $1.3M+8.1% | $1.2M-0.4% | $1.2M-24.7% | $1.6M+44.4% | $1.1M |
| Operating Income | -$594K-16.9% | -$508K-59.7% | -$318K-158.8% | $541K+280.3% | -$300K-240.2% | $214K+172.8% | -$294K-284.9% | $159K |
| Interest Expense | $751K+22.1% | $615K-5.8% | $653K-5.4% | $690K+1.9% | $677K+1.2% | $669K-0.7% | $674K-1.5% | $684K |
| Income Tax | -$244K | $0-100.0% | $8K+118.2% | -$44K | $0 | $0-100.0% | $44K+121.2% | -$208K |
| Net Income | $3.4M+333.4% | -$1.4M-14.8% | -$1.3M-122.2% | -$568K+42.2% | -$982K-39.1% | -$706K+26.6% | -$962K-304.2% | -$238K |
| EPS (Diluted) | $1.17+272.1% | $-0.68+27.7% | $-0.94-203.2% | $-0.31+40.4% | $-0.52-36.8% | $-0.38+26.9% | $-0.52-144.4% | $1.17 |
RHEPA Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $72.2M+20.0% | $60.1M+1.4% | $59.3M-2.0% | $60.5M+0.7% | $60.1M-2.1% | $61.3M+0.2% | $61.2M-1.5% | $62.2M |
| Current Assets | $54.7M+0.2% | $54.6M-6.2% | $58.2M+686.9% | $7.4M+15.3% | $6.4M-75.1% | $25.8M+419.1% | $5.0M+5.7% | $4.7M |
| Cash & Equivalents | $1.0M+150.0% | $400K-20.0% | $500K-14.1% | $582K+16.4% | $500K-28.6% | $700K-12.5% | $800K-20.0% | $1.0M |
| Inventory | $1.4M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $7.7M+76.7% | $4.4M+20.0% | $3.6M+8.3% | $3.4M+65.3% | $2.0M+11.9% | $1.8M+24.1% | $1.5M+4.3% | $1.4M |
| Goodwill | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M |
| Total Liabilities | $69.0M+5.2% | $65.6M+3.4% | $63.4M+0.1% | $63.4M+1.5% | $62.4M-0.5% | $62.7M+1.3% | $62.0M-0.1% | $62.0M |
| Current Liabilities | $89.7M+0.5% | $89.3M+5.9% | $84.2M+497.5% | $14.1M-0.1% | $14.1M-64.8% | $40.1M+1.9% | $39.3M+101.7% | $19.5M |
| Long-Term Debt | $48.6M-0.7% | $48.9M-0.5% | $49.2M-1.1% | $49.7M+0.1% | $49.7M-1.2% | $50.2M+0.5% | $50.0M-1.4% | $50.7M |
| Total Equity | -$1.5M+71.8% | -$5.5M-31.1% | -$4.2M-42.5% | -$2.9M-22.6% | -$2.4M-68.0% | -$1.4M-93.1% | -$734K-496.8% | $185K |
| Retained Earnings | -$84.8M+4.1% | -$88.4M-1.7% | -$87.0M-2.2% | -$85.1M-0.7% | -$84.6M-1.2% | -$83.6M-0.9% | -$82.9M-1.2% | -$81.9M |
RHEPA Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.8M-416.2% | $569K+141.1% | $236K-75.2% | $953K+950.9% | -$112K-122.2% | $505K-15.4% | $597K+136.9% | $252K |
| Capital Expenditures | $283K-4.1% | $295K+353.8% | $65K-35.0% | $100K+185.7% | $35K-89.7% | $340K+518.2% | $55K+31.0% | $42K |
| Free Cash Flow | -$2.1M-859.9% | $274K+60.2% | $171K-80.0% | $853K+680.3% | -$147K-189.1% | $165K-69.6% | $542K+158.1% | $210K |
| Investing Cash Flow | $5.7M+2029.5% | -$295K-353.8% | -$65K+35.0% | -$100K-185.7% | -$35K+89.7% | -$340K-518.2% | -$55K-31.0% | -$42K |
| Financing Cash Flow | -$3.1M-2470.2% | -$121K+79.4% | -$587K+33.5% | -$883K-1277.3% | $75K+113.3% | -$566K+24.6% | -$751K-13.6% | -$661K |
| Dividends Paid | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
RHEPA Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 83.7% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -3.9%+1.1pp | -5.1%-0.6pp | -4.4%-14.0pp | 9.6%+16.7pp | -7.1%-12.0pp | 5.0%+12.1pp | -7.1%-10.6pp | 3.5% |
| Net Margin | 22.3%+36.8pp | -14.4%+3.1pp | -17.5%-7.5pp | -10.0%+13.2pp | -23.2%-6.9pp | -16.3%+7.0pp | -23.3%-18.1pp | -5.3% |
| Return on Equity | N/A | N/A | N/A | 6.4%-46.6pp | 53.0% | N/A | 2.9%-1.1pp | 4.0% |
| Return on Assets | 4.7%+7.1pp | -2.4%-0.3pp | -2.1%-1.2pp | -0.9%+0.7pp | -1.6%-0.5pp | -1.1%+0.4pp | -1.6%-1.2pp | -0.4% |
| Current Ratio | 0.610.0 | 0.61-0.1 | 0.69+0.2 | 0.52+0.1 | 0.45-0.2 | 0.64+0.5 | 0.13-0.1 | 0.24 |
| Debt-to-Equity | -31.59-22.6 | -8.97+2.9 | -11.82+5.2 | -17.03+3.8 | -20.86+14.6 | -35.46+32.7 | -68.13-342.4 | 274.24 |
| FCF Margin | -13.8%-16.5pp | 2.7%+0.3pp | 2.4%-12.7pp | 15.1%+18.6pp | -3.5%-7.3pp | 3.8%-9.3pp | 13.1%+8.5pp | 4.6% |
Note: Shareholder equity is negative (-$2.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What is Regional Health's annual revenue?
Regional Health (RHEPA) reported $18.3M in total revenue for fiscal year 2024. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Regional Health's revenue growing?
Regional Health (RHEPA) revenue grew by 6.8% year-over-year, from $17.2M to $18.3M in fiscal year 2024.
Is Regional Health profitable?
No, Regional Health (RHEPA) reported a net income of -$3.2M in fiscal year 2024, with a net profit margin of -17.5%.
What is Regional Health's earnings per share (EPS)?
Regional Health (RHEPA) reported diluted earnings per share of $-1.73 for fiscal year 2024. This represents a -108.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Regional Health's EBITDA?
Regional Health (RHEPA) had EBITDA of $2.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Regional Health have?
As of fiscal year 2024, Regional Health (RHEPA) had $582K in cash and equivalents against $49.7M in long-term debt.
What is Regional Health's operating margin?
Regional Health (RHEPA) had an operating margin of 0.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Regional Health's net profit margin?
Regional Health (RHEPA) had a net profit margin of -17.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Regional Health's free cash flow?
Regional Health (RHEPA) generated $1.4M in free cash flow during fiscal year 2024. This represents a -48.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Regional Health's operating cash flow?
Regional Health (RHEPA) generated $1.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Regional Health's total assets?
Regional Health (RHEPA) had $60.5M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Regional Health's capital expenditures?
Regional Health (RHEPA) invested $530K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How many shares does Regional Health have outstanding?
Regional Health (RHEPA) had 2M shares outstanding as of fiscal year 2024.
What is Regional Health's debt-to-equity ratio?
Regional Health (RHEPA) had a debt-to-equity ratio of -17.03 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Regional Health's return on assets (ROA)?
Regional Health (RHEPA) had a return on assets of -5.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
Why is Regional Health's debt-to-equity ratio negative or unusual?
Regional Health (RHEPA) has negative shareholder equity of -$2.9M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Regional Health's Piotroski F-Score?
Regional Health (RHEPA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Regional Health's earnings high quality?
Regional Health (RHEPA) has an earnings quality ratio of -0.60x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Regional Health cover its interest payments?
Regional Health (RHEPA) has an interest coverage ratio of 0.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.